These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 9762943)

  • 21. Nonseminomatous germ cell tumors: assessing the need for postchemotherapy contralateral pulmonary resection in patients with ipsilateral complete necrosis.
    Besse B; Grunenwald D; Fléchon A; Caty A; Chevreau C; Culine S; Théodore C; Fizazi K
    J Thorac Cardiovasc Surg; 2009 Feb; 137(2):448-52. PubMed ID: 19185168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcome of patients with residual germ cell or non-germ cell malignancy after resection of primary mediastinal nonseminomatous germ cell cancer.
    Schneider BP; Kesler KA; Brooks JA; Yiannoutsos C; Einhorn LH
    J Clin Oncol; 2004 Apr; 22(7):1195-200. PubMed ID: 15051766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Significance of elevated preoperative alpha-fetoprotein in postchemotherapy residual tumor resection for the disseminated germ cell tumors.
    Kobayashi T; Kawakita M; Terachi T; Habuchi T; Ogawa O; Kamoto T
    J Surg Oncol; 2006 Dec; 94(7):619-23. PubMed ID: 17111392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Excellent outcome in patients with stage I germ cell tumors of the testes: a study of the Children's Cancer Group/Pediatric Oncology Group.
    Schlatter M; Rescorla F; Giller R; Cushing B; Vinocur C; Colombani P; Cullen J; London W; Davis M; Lauer S; Olson T; ;
    J Pediatr Surg; 2003 Mar; 38(3):319-24; discussion 319-24. PubMed ID: 12632342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of necrosis after chemotherapy of advanced germ cell tumors: results of a prospective multicenter trial of the German Testicular Cancer Study Group.
    Albers P; Weissbach L; Krege S; Kliesch S; Hartmann M; Heidenreich A; Walz P; Kuczyk M; Fimmers R;
    J Urol; 2004 May; 171(5):1835-8. PubMed ID: 15076288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors.
    Böhlen D; Borner M; Sonntag RW; Fey MF; Studer UE
    J Urol; 1999 Apr; 161(4):1148-52. PubMed ID: 10081858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Viable malignant germ cell tumor in the postchemotherapy retroperitoneal lymph node dissection specimen: can it be predicted using clinical parameters?
    Spiess PE; Brown GA; Pisters LL; Liu P; Tu SM; Evans JG; Kamat AM; Black P; Tannir NM
    Cancer; 2006 Oct; 107(7):1503-10. PubMed ID: 16944534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical study of retroperitoneal lymph node dissection for patients with advanced germ cell tumors].
    Okamura K; Yuba H; Nishimura T; Mizutani K; Takashi M; Gotoh M; Ono Y; Ohshima S
    Hinyokika Kiyo; 1999 Feb; 45(2):95-101. PubMed ID: 10212781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved long term survival of patients with metastatic nonseminomatous testicular germ cell carcinoma in relation to prognostic classification systems during the cisplatin era.
    Sonneveld DJ; Hoekstra HJ; van der Graaf WT; Sluiter WJ; Mulder NH; Willemse PH; Koops HS; Sleijfer DT
    Cancer; 2001 Apr; 91(7):1304-15. PubMed ID: 11283931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Late relapse of metastatic testicular nonseminomatous germ cell cancer: surgery is needed for cure.
    Geldart TR; Gale J; McKendrick J; Kirby J; Mead G
    BJU Int; 2006 Aug; 98(2):353-8. PubMed ID: 16879677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Repeat retroperitoneal lymphadenectomy in advanced testicular cancer.
    Heidenreich A; Ohlmann C; Hegele A; Beyer J
    Eur Urol; 2005 Jan; 47(1):64-71. PubMed ID: 15582251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prognostic factors for extratesticular involvement in stage I testicular cancer. Apropos of 58 cases].
    Chraibi Y; Culine S; Terrier-Lacombe MJ; Kramar A; Kattan J; Droz JP
    Bull Cancer; 1994 Apr; 81(4):311-7. PubMed ID: 7703548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical outcome of retroperitoneal lymph node dissection after induction chemotherapy for metastatic non-seminomatous germ cell tumors.
    Muramaki M; Hara I; Miyake H; Yamada Y; Okada H; Kamidono S
    Int J Urol; 2004 Sep; 11(9):763-7. PubMed ID: 15379941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Malignant mediastinal germ cell tumors: an intergroup study.
    Billmire D; Vinocur C; Rescorla F; Colombani P; Cushing B; Hawkins E; London WB; Giller R; Lauer S
    J Pediatr Surg; 2001 Jan; 36(1):18-24. PubMed ID: 11150432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Malignant germ cell tumors in childhood: results of the first Italian cooperative study "TCG 91".
    Lo Curto M; Lumia F; Alaggio R; Cecchetto G; Almasio P; Indolfi P; Siracusa F; Bagnulo S; De Bernardi B; De Laurentis T; Di Cataldo A; Tamaro P
    Med Pediatr Oncol; 2003 Nov; 41(5):417-25. PubMed ID: 14515380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resection of small, residual retroperitoneal masses after chemotherapy for nonseminomatous testicular cancer: a decision analysis.
    Steyerberg EW; Marshall PB; Keizer HJ; Habbema JD
    Cancer; 1999 Mar; 85(6):1331-41. PubMed ID: 10189139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Repeat retroperitoneal lymph-node dissection after chemotherapy for metastatic testicular germ cell tumour.
    Willis SF; Winkler M; Savage P; Seckl MJ; Christmas TJ
    BJU Int; 2007 Oct; 100(4):809-12. PubMed ID: 17711512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mature teratoma identified after postchemotherapy surgery in patients with disseminated nonseminomatous testicular germ cell tumors: a plea for an aggressive surgical approach.
    Sonneveld DJ; Sleijfer DT; Koops HS; Keemers-Gels ME; Molenaar WM; Hoekstra HJ
    Cancer; 1998 Apr; 82(7):1343-51. PubMed ID: 9529027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Germ cell tumours of the testis: clinical features, treatment outcome and prognostic factors.
    Bhutani M; Kumar L; Seth A; Thulkar S; Vijayaraghavan M; Kochupillai V
    Natl Med J India; 2002; 15(1):18-21. PubMed ID: 11855586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors in germ cell tumour patients with relapse or progressive disease after first-line chemotherapy: evaluation of a prognostic score for survival after high-dose chemotherapy.
    Sammler C; Beyer J; Bokemeyer C; Hartmann JT; Rick O
    Eur J Cancer; 2008 Jan; 44(2):237-43. PubMed ID: 18055194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.